News

Published on 24 Jan 2022 on Zacks via Yahoo Finance

Is a Surprise Coming for Abbott (ABT) This Earnings Season?


Article preview image

Investors are always looking for stocks that are poised to beat at earnings season and Abbott Laboratories ABT may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because Abbott is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for ABT in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at $1.21 per share for ABT, compared to a broader Zacks Consensus Estimate of $1.18 per share. This suggests that analysts have very recently bumped up their estimates for ABT, giving the stock a Zacks Earnings ESP of +2.82% heading into earnings season.

NYSE.ABT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation

Key Insights Abbott Laboratories to hold its Annual General Meeting on 26th of AprilTotal pay for...

Simply Wall St. via Yahoo Finance 20 Apr 2024

Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript

Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript April 17, 2024 Abbott Laboratorie...

Insider Monkey via Yahoo Finance 18 Apr 2024

Abbott Laboratories: An Exploration into Its Intrinsic Value

In this article, we will take a look into Abbott Laboratories's (NYSE:ABT) DCF analysis, a reliab...

GuruFocus.com via Yahoo Finance 17 Apr 2024

Abbott Labs Stock Falls as Q2 Guidance Outweighs Earnings Beat

Abbott Laboratories' first-quarter earnings on Wednesday exceeded analyst expectations, but its ...

Investopedia 17 Apr 2024

Abbott stock slips despite Q1 beat (NYSE:ABT)

Abbott Laboratories (ABT) stock fell even as its Q1 2024 results exceeded estimates despite a con...

Seeking Alpha 17 Apr 2024

Stocks making the biggest moves midday: United Airlines, Travelers, Abbott Laboratories and more

Shares surged 14% after the airline posted a narrower-than-expected loss in the first quarter....

CNBC 17 Apr 2024

FDA recalls implanted heart devices linked to 14 deaths

Two implanted heart devices used by patients in end-stage heart failure are now under a strict U....

United Press International via Yahoo News 17 Apr 2024

Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript

Image source: The Motley Fool. Abbott Laboratories (NYSE: ABT)Q1 2024 Earnings CallApr 17, 2024, ...

Motley Fool via Yahoo Finance 17 Apr 2024

Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report

Abbott Laboratories came in Wednesday with a "solid" first-quarter report, but Abbott stock slipp...

Investor's Business Daily 17 Apr 2024

Abbott's device sales drive profit beat, but shares fall as forecast disappoints

(Reuters) -Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday on...

Reuters via Yahoo News 17 Apr 2024